Healthequity (HQY) Gains from Investment Securities (2017 - 2026)
Healthequity has reported Gains from Investment Securities over the past 12 years, most recently at $691000.0 for Q1 2026.
- For Q1 2026, Gains from Investment Securities fell 69.32% year-over-year to $691000.0; the TTM value through Jan 2026 reached $8.0 million, down 69.15%, while the annual FY2026 figure was $8.0 million, 69.15% down from the prior year.
- Gains from Investment Securities for Q1 2026 was $691000.0 at Healthequity, down from $844000.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $15.1 million in Q3 2023 and troughed at -$6.4 million in Q1 2022.
- A 5-year average of $3.8 million and a median of $844000.0 in 2025 define the central range for Gains from Investment Securities.
- Biggest five-year swings in Gains from Investment Securities: surged 52300.0% in 2022 and later crashed 116.61% in 2025.
- Year by year, Gains from Investment Securities stood at $1.0 million in 2022, then soared by 825.67% to $9.7 million in 2023, then grew by 7.06% to $10.3 million in 2024, then tumbled by 91.84% to $844000.0 in 2025, then dropped by 18.13% to $691000.0 in 2026.
- Business Quant data shows Gains from Investment Securities for HQY at $691000.0 in Q1 2026, $844000.0 in Q4 2025, and $6.6 million in Q3 2025.